Thrombolex

Funding and NIH signals

• SEC Form D raise Raised $32.78M (Form D filed Mar 12, 2026). SEC Form D 0001703764-26-000003 (Mar 12, 2026)
  Evidence (1 event)

  • Mar 12, 2026 · SEC Form D 0001703764-26-000003
    Name of Issuer: Thrombolex, Inc.; CIK: 1703764; Address: Kingston, NJ; Submission type: D; Filing date: 2026-03-12; Industry Group: Other Health Care; Date of First Sale: 2026-02-26; Types of Securities Offered: Equity, Other (Includes Conversion of Outstanding Notes); Business combination transaction: false; Total Offering Amount: 51105000; Total Amount Sold: 32775000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals